Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline"

Affiliations

¹ Academic Unit of Bone Metabolism, Mellanby Centre for Bone Research and Metabolic Bone Centre, Northern General Hospital, Sheffield, United Kingdom.
² Department of Medicine, Tufts University School of Medicine, Maine Medical Center Research Institute, Scarborough, Maine.

Comment

Richard Eastell et al. J Clin Endocrinol Metab. 2019.

. 2019 Aug 1;104(8):3537-3538.

doi: 10.1210/jc.2019-00777.

¹ Academic Unit of Bone Metabolism, Mellanby Centre for Bone Research and Metabolic Bone Centre, Northern General Hospital, Sheffield, United Kingdom.
² Department of Medicine, Tufts University School of Medicine, Maine Medical Center Research Institute, Scarborough, Maine.

No abstract available

Comment on

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Eastell R, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. J Clin Endocrinol Metab. 2019. PMID: 30907953
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
Gonzalez Rodriguez E, Lamy O. Gonzalez Rodriguez E, et al. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3535-3536. doi: 10.1210/jc.2019-00747. J Clin Endocrinol Metab. 2019. PMID: 30998233 No abstract available.